Ensign Peak Advisors, Inc Guardant Health, Inc. Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 41,450 shares of GH stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,450

Previous 41,450 -0.0%

Holding current value

$1.35 Million

Previous $1.2 Million 20.63%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$16.07 - $31.84 $28,926 - $57,312	1,800 Added 4.54%	41,450 $1.2 Million
Q1 2024 May 14, 2024	SELL	$17.13 - $26.91 $34,260 - $53,820	-2,000 Reduced 4.8%	39,650 $817,000
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $134,875 - $184,375	6,250 Added 17.66%	41,650 $1.13 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $63,867 - $115,930	3,050 Added 9.43%	35,400 $1.27 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $68,760 - $101,280	3,000 Added 10.22%	32,350 $758,000
Q4 2022 Feb 13, 2023	BUY	$25.44 - $59.78 $179,352 - $421,449	7,050 Added 31.61%	29,350 $798,000
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $12.7 Million - $17.7 Million	-289,924 Reduced 92.86%	22,300 $1.2 Million
Q2 2022 Aug 12, 2022	BUY	$28.82 - $77.35 $4,034 - $10,829	140 Added 0.04%	312,224 $12.6 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $14.1 Million - $29.3 Million	291,204 Added 1394.66%	312,084 $20.7 Million
Q4 2021 Feb 11, 2022	BUY	$88.71 - $120.43 $1.85 Million - $2.51 Million	20,880 New	20,880 $2.09 Million
Q1 2021 May 12, 2021	SELL	$127.04 - $179.1 $332,717 - $469,062	-2,619 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$80.32 - $111.8 $210,358 - $292,804	2,619 New	2,619 $293,000

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Guardant Health, Inc. Transaction History